Neoprofen, Lysakare(lysine)
LysaKare, Neoprofen (lysine) is a small molecule pharmaceutical. Lysine was first approved as Neoprofen on 2006-04-13. It is used to treat nutritional and metabolic diseases in the USA. It has been approved in Europe to treat radiation injuries. The pharmaceutical is active against prostaglandin G/H synthase 2 and prostaglandin G/H synthase 1. In addition, it is known to target acid-sensing ion channel 1, G-protein coupled receptor family C group 6 member A, vasopressin V1b receptor, oxytocin receptor, sodium-coupled monocarboxylate transporter 1, nitric oxide synthase, inducible, peroxisome proliferator-activated receptor gamma, vasopressin V1a receptor, and vasopressin V2 receptor.
Download report
Favorite
Commercial
Trade Name
FDA
EMA
Neoprofen (generic drugs available since 2016-03-30)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Ibuprofen lysine
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| NEOPROFEN | Recordati | N-021903 RX | 2006-04-13 | 1 products, RLD, RS |
Indications
FDA
EMA
Indication | Ontology | MeSH | ICD-10 |
|---|---|---|---|
| nutritional and metabolic diseases | — | D009750 | — |
Agency Specific
FDA
EMA
No data
Patent Expiration
Patent | Expires | Flag | FDA Information |
|---|---|---|---|
| Ibuprofen Lysine, Neoprofen, Recordati Rare | |||
| 8415337 | 2032-03-02 | DS, DP | |
ATC Codes
A: Alimentary tract and metabolism drugs
— A12: Mineral supplements
— A12A: Calcium supplements
— A12AA: Calcium
— A12AA09: Calcium citrate lysine complex
B: Blood and blood forming organ drugs
— B05: Blood substitutes and perfusion solutions
— B05X: I.v. solution additives
— B05XB: Amino acids, i.v. solution additive
— B05XB03: Lysine
V: Various drug classes in atc
— V03: All other therapeutic products
— V03A: All other therapeutic products
— V03AF: Detoxifying agents for antineoplastic treatment
— V03AF11: Arginine and lysine
HCPCS
No data
Clinical
Clinical Trials
667 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Pain | D010146 | EFO_0003843 | R52 | 10 | 12 | 25 | 27 | 13 | 86 |
| Postoperative pain | D010149 | G89.18 | 3 | 8 | 13 | 22 | 12 | 57 | |
| Healthy volunteers/patients | — | 45 | — | — | 3 | 7 | 55 | ||
| Patent ductus arteriosus | D004374 | HP_0001643 | Q25.0 | 2 | 9 | 10 | 9 | 12 | 39 |
| Fever | D005334 | HP_0001945 | R50.9 | 2 | — | 5 | 10 | 3 | 20 |
| Acute pain | D059787 | R52 | 2 | 2 | 5 | 7 | 1 | 17 | |
| Low back pain | D017116 | HP_0003419 | M54.5 | — | 2 | 4 | 9 | 2 | 16 |
| Osteoarthritis | D010003 | EFO_0002506 | M15-M19 | 3 | 3 | 6 | 2 | — | 14 |
| Analgesia | D000698 | — | 2 | 6 | 6 | — | 13 | ||
| Knee osteoarthritis | D020370 | EFO_0004616 | M17 | 2 | 1 | — | 3 | 3 | 9 |
Show 86 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Neoplasms | D009369 | C80 | — | 2 | 1 | — | 1 | 4 | |
| Local anesthesia | D000772 | — | 2 | 1 | — | 1 | 3 | ||
| Pregnancy | D011247 | EFO_0002950 | Z33.1 | — | 1 | 1 | — | 1 | 3 |
| Breast neoplasms | D001943 | EFO_0003869 | C50 | 1 | — | 1 | — | 1 | 3 |
| Altitude sickness | D000532 | EFO_1000782 | T70.29 | 1 | — | 1 | — | 1 | 3 |
| Impacted tooth | D014095 | HP_0011079 | K01.1 | — | 1 | 2 | — | 1 | 3 |
| Sprains and strains | D013180 | — | — | 3 | — | — | 3 | ||
| Respiratory tract infections | D012141 | J06.9 | — | 1 | 2 | — | — | 2 | |
| Cachexia | D002100 | HP_0004326 | R64 | — | — | 1 | — | 1 | 2 |
| Musculoskeletal pain | D059352 | — | 1 | 1 | — | — | 2 |
Show 44 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Tuberculosis | D014376 | EFO_0000774 | A15-A19 | — | 2 | — | — | — | 2 |
| Phimosis | D010688 | EFO_1001104 | N47.1 | 1 | 1 | — | — | — | 2 |
| Paraphimosis | D010263 | EFO_1001086 | N47.2 | 1 | 1 | — | — | — | 2 |
| Balanitis | D001446 | EFO_1000833 | N48.1 | 1 | 1 | — | — | — | 2 |
| Retinopathy of prematurity | D012178 | EFO_1001158 | H35.1 | — | 1 | — | — | 1 | 2 |
| Malaria | D008288 | EFO_0001068 | B54 | 1 | 2 | — | — | — | 2 |
| Abdominal hernia | D046449 | K46 | — | 1 | — | — | 1 | 2 | |
| Bronchopulmonary dysplasia | D001997 | P27.8 | — | 2 | — | — | — | 2 | |
| Soft tissue injuries | D017695 | — | 1 | — | — | 1 | 2 | ||
| Epilepsy | D004827 | EFO_0000474 | G40.9 | — | 1 | — | — | 1 | 2 |
Show 34 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Therapeutic equivalency | D013810 | 4 | — | — | — | — | 4 | ||
| Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | 2 | — | — | — | 1 | 3 |
| Heart failure | D006333 | EFO_0003144 | I50 | 2 | — | — | — | 1 | 3 |
| Pharmacokinetics | D010599 | 1 | — | — | — | 1 | 2 | ||
| Drug interactions | D004347 | 1 | — | — | — | — | 1 | ||
| Pure autonomic failure | D054970 | 1 | — | — | — | — | 1 | ||
| Orthostatic hypotension | D007024 | I95.1 | 1 | — | — | — | — | 1 | |
| Hematologic neoplasms | D019337 | 1 | — | — | — | — | 1 | ||
| Precursor cell lymphoblastic leukemia-lymphoma | D054198 | C91.0 | 1 | — | — | — | — | 1 | |
| Bcr-abl positive chronic myelogenous leukemia | D015464 | EFO_0000340 | 1 | — | — | — | — | 1 |
Show 12 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Cystic fibrosis | D003550 | EFO_0000390 | E84 | — | — | — | — | 6 | 6 |
| Hyperglycemia | D006943 | HP_0003074 | R73.9 | — | — | — | — | 2 | 2 |
| Leg ulcer | D007871 | — | — | — | — | 2 | 2 | ||
| Pseudomonas aeruginosa | D011550 | NCBITaxon_287 | — | — | — | — | 1 | 1 | |
| Pseudomonas infections | D011552 | EFO_0001076 | — | — | — | — | 1 | 1 | |
| Colonic neoplasms | D003110 | C18 | — | — | — | — | 1 | 1 | |
| Arthritis | D001168 | EFO_0005856 | M05-M14 | — | — | — | — | 1 | 1 |
| Urinary calculi | D014545 | N20.9 | — | — | — | — | 1 | 1 | |
| Pediatric obesity | D063766 | — | — | — | — | 1 | 1 | ||
| Appetitive behavior | D001070 | — | — | — | — | 1 | 1 |
Show 62 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | LYSINE |
| INN | lysine |
| Description | Lysine is a diamino acid that is caproic (hexanoic) acid bearing two amino substituents at positions 2 and 6. It has a role as a Daphnia magna metabolite. It is an alpha-amino acid, a diamino acid and a polar amino acid. It contains a 4-aminobutyl group. It is functionally related to a hexanoic acid. It is a conjugate base of a lysinium(1+). It is a conjugate acid of a lysinate. |
| Classification | Small molecule |
| Drug class | — |
| Image (chem structure or protein) | |
| Structure (InChI/SMILES or Protein Sequence) | NCCCC[C@H](N)C(=O)O |
Identifiers
| PDB | — |
| CAS-ID | 56-87-1 |
| RxCUI | — |
| ChEMBL ID | CHEMBL8085 |
| ChEBI ID | 18019 |
| PubChem CID | 866 |
| DrugBank | DB00123 |
| UNII ID | K3Z4F929H6 (ChemIDplus, GSRS) |
Target
Agency Approved
PTGS2
PTGS2
PTGS1
PTGS1
Organism
Homo sapiens
Gene name
PTGS2
Gene synonyms
COX2
NCBI Gene ID
Protein name
prostaglandin G/H synthase 2
Protein synonyms
COX-2, cyclooxygenase 2, cyclooxygenase 2b, Cyclooxygenase-2, PGH synthase 2, PGHS-2, PHS II, Prostaglandin H2 synthase 2, Prostaglandin-endoperoxide synthase 2, prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
Uniprot ID
Mouse ortholog
Ptgs2 (19225)
prostaglandin G/H synthase 2 (Q543K3)
Alternate
ASIC1
ASIC1
GPRC6A
GPRC6A
AVPR1B
AVPR1B
OXTR
OXTR
SLC5A8
SLC5A8
NOS2
NOS2
PPARG
PPARG
AVPR1A
AVPR1A
AVPR2
AVPR2
Organism
Homo sapiens
Gene name
ASIC1
Gene synonyms
ACCN2, BNAC2
NCBI Gene ID
Protein name
acid-sensing ion channel 1
Protein synonyms
acid sensing (proton gated) ion channel 1, acid-sensing ion channel 1a protein, Amiloride-sensitive cation channel 2, neuronal, BNaC2, Brain sodium channel 2, Cation channel, amiloride-sensitive, neuronal, 2
Uniprot ID
Mouse ortholog
Asic1 (11419)
acid-sensing ion channel 1 (Q6NXK8)
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 422,139 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
98,197 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more